FDA opposes Avastin for breast cancer
WWJ's Marie Osborne spoke with Lawrence Flaherty, professor of oncology at Wayne State University and the Karmanos Cancer Institute, about an FDA panel's unanimous recommendation that the drug Avastin no longer be sold as a treatment for breast cancer. "I think the FDA got it right," Flaherty said. The panel\'s decision does not affect other uses for which Avastin is approved, including advanced non-small-cell lung cancer, metastatic colorectal cancer, metastatic renal cell carcinoma, and glioblastoma brain tumors.